RMD · ResMed Inc
AI read · Good for RMD
The AI's read
The results show ResMed is selling more and keeping more from each sales dollar after product costs. Profit per share rose faster than sales. Its full-year forecast expects slower profit-per-share growth than this quarter delivered, which tempers the report. Still, ResMed repeated its forecast for growth, and the quarter improved across sales, product costs, and profit.